[ Back to EurekAlert! ]

Contact: Steve Graff
Thomas Jefferson University

Karen Knudsen, Ph.D., Thomas Jefferson University

Caption: Targeting dual roles of PARP-1 may slow cancer growth and progression, Jefferson's Kimmel Cancer Center researchers say.

Credit: TJU

Usage Restrictions: None

Related news release: Doubling up on advanced prostate cancer with PARP inhibitors

[ Back to EurekAlert! ]